Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol.
<h4>Background</h4>Chronic low back pain (CLBP) and fibromyalgia (FM) are leading causes of suffering, disability, and social costs. Current pharmacological treatments do not target molecular mechanisms driving CLBP and FM, and no validated biomarkers are available, hampering the develop...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0312061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849711454744215552 |
|---|---|
| author | Michele Curatolo Abby P Chiu Catherine Chia Ava Ward Savera Khan Sandra K Johnston Rebecca M Klein Darrell A Henze Wentao Zhu Daniel Raftery |
| author_facet | Michele Curatolo Abby P Chiu Catherine Chia Ava Ward Savera Khan Sandra K Johnston Rebecca M Klein Darrell A Henze Wentao Zhu Daniel Raftery |
| author_sort | Michele Curatolo |
| collection | DOAJ |
| description | <h4>Background</h4>Chronic low back pain (CLBP) and fibromyalgia (FM) are leading causes of suffering, disability, and social costs. Current pharmacological treatments do not target molecular mechanisms driving CLBP and FM, and no validated biomarkers are available, hampering the development of effective therapeutics. Omics research has the potential to substantially advance our ability to develop mechanism-specific therapeutics by identifying pathways involved in the pathophysiology of CLBP and FM, and facilitate the development of diagnostic, predictive, and prognostic biomarkers. We will conduct a blood and urine multi-omics study in comprehensively phenotyped and clinically characterized patients with CLBP and FM. Our aims are to identify molecular pathways potentially involved in the pathophysiology of CLBP and FM that would shift the focus of research to the development of target-specific therapeutics, and identify candidate diagnostic, predictive, and prognostic biomarkers.<h4>Methods</h4>We are conducting a prospective cohort study of adults ≥18 years of age with CLBP (n=100) and FM (n=100), and pain-free controls (n=200). Phenotyping measures include demographics, medication use, pain-related clinical characteristics, physical function, neuropathic components (quantitative sensory tests and DN4 questionnaire), pain facilitation (temporal summation), and psychosocial function as moderator. Blood and urine samples are collected to analyze metabolomics, lipidomics and proteomics. We will integrate the overall omics data to identify common mechanisms and pathways, and associate multi-omics profiles to pain-related clinical characteristics, physical function, indicators of neuropathic pain, and pain facilitation, with psychosocial variables as moderators.<h4>Discussion</h4>Our study addresses the need for a better understanding of the molecular mechanisms underlying chronic low back pain and fibromyalgia. Using a multi-omics approach, we hope to identify converging evidence for potential targets of future therapeutic developments, as well as promising candidate biomarkers for further investigation by biomarker validation studies. We believe that accurate patient phenotyping will be essential for the discovery process, as both conditions are characterized by high heterogeneity and complexity, likely rendering molecular mechanisms phenotype specific. |
| format | Article |
| id | doaj-art-e916f7d383df4b05912495734fd44556 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-e916f7d383df4b05912495734fd445562025-08-20T03:14:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01204e031206110.1371/journal.pone.0312061Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol.Michele CuratoloAbby P ChiuCatherine ChiaAva WardSavera KhanSandra K JohnstonRebecca M KleinDarrell A HenzeWentao ZhuDaniel Raftery<h4>Background</h4>Chronic low back pain (CLBP) and fibromyalgia (FM) are leading causes of suffering, disability, and social costs. Current pharmacological treatments do not target molecular mechanisms driving CLBP and FM, and no validated biomarkers are available, hampering the development of effective therapeutics. Omics research has the potential to substantially advance our ability to develop mechanism-specific therapeutics by identifying pathways involved in the pathophysiology of CLBP and FM, and facilitate the development of diagnostic, predictive, and prognostic biomarkers. We will conduct a blood and urine multi-omics study in comprehensively phenotyped and clinically characterized patients with CLBP and FM. Our aims are to identify molecular pathways potentially involved in the pathophysiology of CLBP and FM that would shift the focus of research to the development of target-specific therapeutics, and identify candidate diagnostic, predictive, and prognostic biomarkers.<h4>Methods</h4>We are conducting a prospective cohort study of adults ≥18 years of age with CLBP (n=100) and FM (n=100), and pain-free controls (n=200). Phenotyping measures include demographics, medication use, pain-related clinical characteristics, physical function, neuropathic components (quantitative sensory tests and DN4 questionnaire), pain facilitation (temporal summation), and psychosocial function as moderator. Blood and urine samples are collected to analyze metabolomics, lipidomics and proteomics. We will integrate the overall omics data to identify common mechanisms and pathways, and associate multi-omics profiles to pain-related clinical characteristics, physical function, indicators of neuropathic pain, and pain facilitation, with psychosocial variables as moderators.<h4>Discussion</h4>Our study addresses the need for a better understanding of the molecular mechanisms underlying chronic low back pain and fibromyalgia. Using a multi-omics approach, we hope to identify converging evidence for potential targets of future therapeutic developments, as well as promising candidate biomarkers for further investigation by biomarker validation studies. We believe that accurate patient phenotyping will be essential for the discovery process, as both conditions are characterized by high heterogeneity and complexity, likely rendering molecular mechanisms phenotype specific.https://doi.org/10.1371/journal.pone.0312061 |
| spellingShingle | Michele Curatolo Abby P Chiu Catherine Chia Ava Ward Savera Khan Sandra K Johnston Rebecca M Klein Darrell A Henze Wentao Zhu Daniel Raftery Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol. PLoS ONE |
| title | Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol. |
| title_full | Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol. |
| title_fullStr | Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol. |
| title_full_unstemmed | Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol. |
| title_short | Multi-omics profiles of chronic low back pain and fibromyalgia-Study protocol. |
| title_sort | multi omics profiles of chronic low back pain and fibromyalgia study protocol |
| url | https://doi.org/10.1371/journal.pone.0312061 |
| work_keys_str_mv | AT michelecuratolo multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT abbypchiu multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT catherinechia multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT avaward multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT saverakhan multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT sandrakjohnston multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT rebeccamklein multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT darrellahenze multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT wentaozhu multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol AT danielraftery multiomicsprofilesofchroniclowbackpainandfibromyalgiastudyprotocol |